PIH14 COST-EFFECTIVENESS OF A HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLESTIMULATING HORMONE (RFSH) IN PATIENTS PARTICIPATING IN AN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAM
Abstract
Authors
C Vicente Y Poon C Piwko